Search Results 501-510 of 6481 for 谷歌搜索引擎留痕外推技术咨询邮箱：lgooxc@hotmail.com

1. A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

   About this study. This is an open-label extension study to Study 200622.In this study subjects from Study 200622 will be continued on 4-weekly dosing with ...

2. Collaborators - Brain Adaptation and Stimulation: Brian N. Lundstrom - Mayo Clinic Research

   Collaborators. Dr. Lundstrom's team collaborates and shares support staff with the Bioelectronics Neurophysiology and Engineering Laboratory of Gregory A.

3. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

4. A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients with Parkinson's Disease - Mayo Clinic

   Clinical Trials · A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients ...

5. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

   Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

6. Melanoma Research Program - Contact Us

   Use our online contact form to submit nonpatient inquiries about the Melanoma and Skin Cancer Research Program at Mayo Clinic.

7. Validation of Uroflow Trace (R) Mobile Application - Mayo Clinic

   The purpose of this study is to see if the Uroflow Trace (r) mobile application provides an accurate representation of urinary flow tracing by comparing it to a ...

8. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

9. Early Naturalistic Hands-on Autism Caregiver Training - Mayo Clinic

   The purpose of this study is to pilot test the ENHANCE intervention to evaluate methodology, feasibility based on caregiver input, and preliminary caregiver ...

10. Ophthalmology Physician Update e-Edition - Mayo Clinic

    April 17, 2025. A triannual publication for physicians that discusses trends and advances in ophthalmology at Mayo Clinic ...